Although 5–10% of breast cancers are attributable to high-penetrance germline mutations—most notably in BRCA1, BRCA2, TP53, and PTEN—an additional 15–20% exhibit familial aggregation without a single identified high-risk gene [8]. This evidence concerns the gene PTEN and breast cancer.